Galantamine (Mylan Institutional Inc.)
Welcome to the PulseAid listing for the Galantamine drug offered from Mylan Institutional Inc.. This Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Mylan Institutional Inc. |
NON-PROPRIETARY NAME: | galantamine |
SUBSTANCE NAME: | GALANTAMINE HYDROBROMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2009-11-09 |
END MARKETING DATE: | 0000-00-00 |
Galantamine HUMAN PRESCRIPTION DRUG Details:
Item Description | Galantamine from Mylan Institutional Inc. |
LABELER NAME: | Mylan Institutional Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 4(mg/1) |
START MARKETING DATE: | 2009-11-09 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 51079-852_5b33322a-d1fc-0bdc-e053-2a91aa0aeaec |
PRODUCT NDC: | 51079-852 |
APPLICATION NUMBER: | ANDA077590 |
Other GALANTAMINE HYDROBROMIDE Pharmaceutical Manufacturers / Labelers: